Successes and challenges of NK immunotherapy : increasing anti-tumor efficacy /: increasing anti-tumor efficacy. (2021)

• Record Type: Book
• Further Information: Note: Edited by Benjamin Bonavida, Anahid Jewett.
• Editors: Bonavida, Benjamin; Jewett, Anahid
• Contents: Section 1: Modulation of NK Antitumor Activities 1. Engineered Human Pluripotent Stem Cell-Derived NK Cells with Improved Anti-tumor Activity 2. The Cancer - NK cell Immunity Cycle 3. Immunometabolic reprogramming of NK cells for immunotherapy of solid tumors 4. Immunoregulation of NK cells: Similarities and Differences Compared to T cells 5. Tracking the decay of TGFb-resistant NK cells identifies an immune clock of innate cell aging Section 2: Regulation of NK Antitumor Activities 6. Oncolytic virus therapy for cancer; role in activation of NK cells 7. Rendering NK cells resistant to immune suppression: genetic modification with a dominant negative receptor for TGF-Beta 8. Cystatin F, an inhibitor of cysteine cathepsins, regulates the cytotoxicity of NK cells 9. The NCR2-PCNA Immune Checkpoint and Natural Killer-based immunotherapy 10. Tumor derived soluble human NKG2D ligand mediated perturbations in NK cell metabolism and therapeutic implications 11. The expression of high affinity recombinant Fc receptors by engineered natural killer cells to enhance cancer cell killing by ADCC Section 3: NK Antitumor Immunotherapy 12. The many key functions of Natural Killers cells in premalignant and malignant stages of tumorigenesis; when these gatekeepers are gone or defective anarchy ensues 13. Phenotypic plasticity: the emergence of cancer stem cells and collective cell migration 14. Stem cell-engineered invariant natural killer T cells for cancer immunotherapy 15. Natural killer cells in the glioblastoma stem cell niche microenvironment 16. CAR-redirected Cytokine-Induced Killer lymphocytes against sarcomas 17. The Effect of Natural Killer Cells on HIV-1 Rebound in Humanized Mice Section 4: NK Antitumor Immunotherapy 2 18. NK cells are innate actors in the immunosurveillance of melanoma 19. Patients with prostate cancer associate with altered features of Natural Killer cells in terms of pro-angiogenic function and M2-like macrophage polarization capacity 20. New therapeutic approaches to target malignant gliomas 21. Mobilizing Human iNKT cells for Cancer Immunotherapies 22. Initial Innate Immune Responses to Tumor Metastasis 23. Regulating NK cell homeostasis and function by tumor associated NKG2D ligand MIC 24. Natural Killer Cells in Cancer Immunotherapy and Oncolytic Virotherapy Section 5: General Concluding Remarks and Future Perspectives
• Publisher Details: Amsterdam : Academic Press
• Publication Date: 2021
• Extent: 1 online resource
• Subjects: 616.99406; Cancer -- Immunotherapy; Killer cells
• Languages: English
• ISBNs: 9780128243961
• Related ISBNs: 9780128243756
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.